Keywords: Merck & Co, Simcere Pharma, Joint venture, JV, China

Merck & Co sets up China marketing JV with Simcere

Article | 22 July 2011

Print This

US pharma giant Merck & Co (NYSE: MRK) has signed a framework agreement with leading Chinese drugmaker Simcere Pharmaceuticals (NYSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in